文献速递鼻科

口服激素对鼻息肉术后短期结局无额外获益

Lack of additive benefit of oral steroids on short-term postoperative outcomes in nasal polyposis.
PubMed 文献 · Laryngoscope · 2019-11-22

本研究前瞻性随机纳入70例内镜鼻窦术后慢性鼻窦炎伴鼻息肉(CRSwNP)患者,比较术后4周口服激素递减剂量联合鼻腔冲洗与单纯鼻腔冲洗的疗效。结果显示两组在症状总分、生活质量、内镜表现及嗅觉方面均改善,但无显著组间差异,提示术后口服激素不应常规推荐。

要点

  • 术后口服激素联合鼻腔冲洗不优于单纯鼻腔冲洗。
  • 两组症状、生活质量、内镜和嗅觉均改善但无差异。
  • 不推荐术后常规使用口服激素。

核心结论

  • 术后口服激素作为CRSwNP的附加治疗不改善鼻窦和生活质量结局,不应常规推荐。

研究设计与样本

  • 前瞻性随机对照研究,纳入70例对最大药物治疗抵抗且接受内镜鼻窦手术的CRSwNP患者,治疗组35例术后4周口服激素递减剂量加鼻腔冲洗,对照组35例仅鼻腔冲洗。

主要发现

  • 随访4周后,两组在5项症状总分、生活质量、内镜表现(除结痂在两组均增加外)和嗅觉方面均改善,但口服激素组与对照组间无显著差异。

关键数值与推荐

  • 疗效评估采用5项症状总分(T5SS)、息肉大小评分、Barcelona嗅觉测试24和SF-36生活质量问卷。

临床怎么用

  • CRSwNP患者内镜鼻窦术后不应常规给予口服激素作为附加治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: There is a lack of evidence concerning the efficacy of oral corticosteroids (OCS) as a postoperative treatment for patients with chronic rhinosinusitis with nasal polyps (CRSwNP). The objective of our study was to determine the short-term additive benefit of postoperative OCS in CRSwNP patients. METHODS: We prospectively randomized CRSwNP patients who were treated by endoscopic sinus surgery. All patients were resistant to maximum medical treatment according to European position paper on rhinosinusitis and nasal polyps 2012 guidelines. Treatment group received postoperative OCS in descending doses plus nasal douching over a period of 4 weeks, whereas the control group received only nasal douching. The efficacy of OCS was determined by a total 5 item symptoms score (T5SS), polyp size score, Barcelona Smell Test 24 and Medical Outcome Study Short Form-36 questionnaire for quality of life (QoL). RESULTS: Of the 70 enrolled patients, 35 were in the treatment group and 35 in the control group. After 4 weeks of follow-up, patients from both groups improved in T5SS, QoL, endoscopic findings (except for crusts that increased in both) and sense of smell, without significant differences between OCS and control groups. CONCLUSION: Postoperative OCS as an add-on treatment for CRSwNP patients does not improve sinonasal and QoL outcomes; thus, they should not be routinely recommended. LEVEL OF EVIDENCE: Ib Laryngoscope, 2019.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Arancibia C, Langdon C, Mullol J, et al. Lack of additive benefit of oral steroids on short-term postoperative outcomes in nasal polyposis. Laryngoscope. 2019. PMID: 31755989. doi:10.1002/lary.28347

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。